← Leaderboards
Ajit Harishkumar Goenka
University Of California, San Francisco
$3,380,410
Attributed
$5,061,565
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,061,565 · 2
By mechanism
R01$5,061,565 · 2
Top collaborators
- Eric Collisson5 shared
- Zhen Jane Wang5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Renuka Sriram$2,377,614
- Zhen Jane Wang$4,501,373
- Anne M. Suskind$3,530,297
- John Matthew Inadomi$9,020,701
- Matilda F Chan$4,592,355
Others in their field
Other Emerging Leaders on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,381,339
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Craig Reist · Research Triangle Institute$22,725,934
- Lisa Newman · Research Triangle Institute$22,725,934
Research focus
Operative Surgical ProceduresProspectiveInnovationNeoplasm MetastasisPancreatic Ductal AdenocarcinomaPositron-Emission TomographyCostImageMalignant Neoplasm Of PancreasNeoadjuvant TherapyBiological MarkersCancer EtiologyPositioning AttributeFutilityCessation Of LifeBiologyDetectionExcisionKras2 GeneLiquid BiopsyMalignant NeoplasmsMetabolicCa-19-9 AntigenRadiologist
Grant awards (9)
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)$955,352
R01 · FY2025 · CA · contact PI
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$1
R01 · FY2025 · CA
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$702,342
R01 · FY2024 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)$444,504
R01 · FY2024 · CA · contact PI
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$598,284
R01 · FY2023 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)$592,291
R01 · FY2023 · CA · contact PI
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$596,548
R01 · FY2022 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)$547,685
R01 · FY2022 · CA · contact PI
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy$624,558
R01 · FY2021 · CA